| __timestamp | Alpine Immune Sciences, Inc. | Madrigal Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 12199547 | 68205000 |
| Thursday, January 1, 2015 | 16054000 | 54218000 |
| Friday, January 1, 2016 | 23316000 | 15934000 |
| Sunday, January 1, 2017 | 10626000 | 24390000 |
| Monday, January 1, 2018 | 28970000 | 25389000 |
| Tuesday, January 1, 2019 | 35847000 | 72324000 |
| Wednesday, January 1, 2020 | 27185000 | 184809000 |
| Friday, January 1, 2021 | 58742000 | 205164000 |
| Saturday, January 1, 2022 | 70243000 | 245441000 |
| Sunday, January 1, 2023 | 80904000 | 271823000 |
Data in motion
In the competitive landscape of biotechnology, research and development (R&D) spending is a critical indicator of a company's commitment to innovation. Over the past decade, Madrigal Pharmaceuticals, Inc. and Alpine Immune Sciences, Inc. have demonstrated contrasting strategies in their R&D investments.
From 2014 to 2023, Madrigal Pharmaceuticals increased its R&D budget by nearly 300%, peaking in 2023 with a staggering 272 million dollars. This reflects a strategic focus on advancing their pipeline, particularly in the field of liver disease treatments. In contrast, Alpine Immune Sciences, while also increasing its R&D spending, showed a more moderate growth of approximately 560%, reaching 81 million dollars in 2023. This growth underscores their commitment to developing innovative immunotherapies.
These trends highlight the dynamic nature of biotech investments and the varying approaches companies take to drive innovation and growth.
Zoetis Inc. or Alpine Immune Sciences, Inc.: Who Invests More in Innovation?
Research and Development Expenses Breakdown: Regeneron Pharmaceuticals, Inc. vs Alpine Immune Sciences, Inc.
Who Prioritizes Innovation? R&D Spending Compared for GSK plc and Alpine Immune Sciences, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Intra-Cellular Therapies, Inc. and Madrigal Pharmaceuticals, Inc.
R&D Insights: How Madrigal Pharmaceuticals, Inc. and ADMA Biologics, Inc. Allocate Funds
Research and Development Investment: Madrigal Pharmaceuticals, Inc. vs Rhythm Pharmaceuticals, Inc.
Comparing Innovation Spending: Madrigal Pharmaceuticals, Inc. and HUTCHMED (China) Limited
R&D Spending Showdown: Madrigal Pharmaceuticals, Inc. vs Galapagos NV
Research and Development Investment: Axsome Therapeutics, Inc. vs Alpine Immune Sciences, Inc.
R&D Spending Showdown: Alpine Immune Sciences, Inc. vs CymaBay Therapeutics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Alpine Immune Sciences, Inc. and Viking Therapeutics, Inc.
Research and Development Expenses Breakdown: Alpine Immune Sciences, Inc. vs Viridian Therapeutics, Inc.